These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37062821)

  • 1. Successful management of poisoning with ivermectin (Mectizan) in the Obala health district (Centre Region, Cameroon): a case report.
    Donfo-Azafack C; Nana-Djeunga HC; Wafeu-Sadeu G; Dongmo-Yemele R; Kamgno J
    J Med Case Rep; 2023 Apr; 17(1):141. PubMed ID: 37062821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for macrofilaricidal activity of ivermectin against female Onchocerca volvulus: further analysis of a clinical trial in the Republic of Cameroon indicating two distinct killing mechanisms.
    Duke BO
    Parasitology; 2005 Apr; 130(Pt 4):447-53. PubMed ID: 15830819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.
    Kamgno J; Pion SD; Chesnais CB; Bakalar MH; D'Ambrosio MV; Mackenzie CD; Nana-Djeunga HC; Gounoue-Kamkumo R; Njitchouang GR; Nwane P; Tchatchueng-Mbouga JB; Wanji S; Stolk WA; Fletcher DA; Klion AD; Nutman TB; Boussinesq M
    N Engl J Med; 2017 Nov; 377(21):2044-2052. PubMed ID: 29116890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in incidence of serious adverse events after onchocerciasis treatment with ivermectin in areas of Cameroon co-endemic for loiasis.
    Twum-Danso NA; Meredith SE
    Trop Med Int Health; 2003 Sep; 8(9):820-31. PubMed ID: 12950668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point prevalence mapping reveals hotspot for onchocerciasis transmission in the Ndikinimeki Health District, Centre Region, Cameroon.
    Aza'ah RA; Sumo L; Ntonifor NH; Bopda J; Bamou RH; Nana-Djeunga HC
    Parasit Vectors; 2020 Oct; 13(1):519. PubMed ID: 33066826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
    Wanji S; Chounna Ndongmo WP; Fombad FF; Kengne-Ouafo JA; Njouendou AJ; Longang Tchounkeu YF; Koudou B; Bockarie M; Fobi G; Roungou JB; Enyong PA
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006750. PubMed ID: 30226900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ivermectin distribution and the cultural context of forest onchocerciasis in South Province, Cameroon.
    Hewlett BS; Kollo B; Cline BL
    Am J Trop Med Hyg; 1996 May; 54(5):517-22. PubMed ID: 8644908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
    Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M
    Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of repeated ivermectin treatments against onchocerciasis on the transmission of loiasis: an entomologic evaluation in central Cameroon.
    Kouam MK; Tchatchueng-Mbougua JB; Demanou M; Boussinesq M; Pion SD; Kamgno J
    Parasit Vectors; 2013 Sep; 6(1):283. PubMed ID: 24289520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Audit of the community-directed treatment with ivermectin (CDTI) for onchocerciasis and factors associated with adherence in three regions of Cameroon.
    Kamga GR; Dissak-Delon FN; Nana-Djeunga HC; Biholong BD; Ghogomu SM; Souopgui J; Kamgno J; Robert A
    Parasit Vectors; 2018 Jun; 11(1):356. PubMed ID: 29921312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of the microfilarial reservoir of Loa loa in the human host and its implications for monitoring the progr,ammes of Community-Directed Treatment with Ivermectin carried out in Africa.
    Pion DS; Gardon J; Kamgno J; Gardon-Wendel N; Chippaux JP; Boussinesq M
    Parasitology; 2004 Nov; 129(Pt 5):613-26. PubMed ID: 15552406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Mectizan Donation Program (MDP).
    Thylefors B
    Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():39-44. PubMed ID: 18718154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study.
    Pion SD; Nana-Djeunga H; Niamsi-Emalio Y; Chesnais CB; Deléglise H; Mackenzie C; Stolk W; Fletcher DA; Klion AD; Nutman TB; Boussinesq M; Kamgno J
    Lancet Infect Dis; 2020 Jan; 20(1):102-109. PubMed ID: 31676244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of the prevention of post-ivermectin Loa loa encephalopathy by administration of initial low dose].
    Kamgno J; Gardon J; Boussinesq M
    Med Trop (Mars); 2000; 60(3):275-7. PubMed ID: 11258063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between oral declaration on adherence to ivermectin treatment and parasitological indicators of onchocerciasis in an area of persistent transmission despite a decade of mass drug administration in Cameroon.
    Wanji S; Kengne-Ouafo JA; Esum ME; Chounna PW; Adzemye BF; Eyong JE; Jato I; Datchoua-Poutcheu FR; Abong RA; Enyong P; Taylor DW
    Parasit Vectors; 2015 Dec; 8():667. PubMed ID: 26715524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge/perception and attitude/practices of populations of two first-line communities of the Centre Region of Cameroon regarding onchocerciasis and black fly nuisance and bio-ecology.
    Domche A; Nana-Djeunga HC; Yemeli LD; Nanga CL; Boussinesq M; Njiokou F; Pion S; Kamgno J
    Parasit Vectors; 2021 Oct; 14(1):546. PubMed ID: 34688311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproductive status of Onchocerca volvulus after ivermectin treatment in an ivermectin-naïve and a frequently treated population from Cameroon.
    Nana-Djeunga HC; Bourguinat C; Pion SD; Bopda J; Kengne-Ouafo JA; Njiokou F; Prichard RK; Wanji S; Kamgno J; Boussinesq M
    PLoS Negl Trop Dis; 2014 Apr; 8(4):e2824. PubMed ID: 24762816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis.
    Abegunde AT; Ahuja RM; Okafor NJ
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011146. PubMed ID: 26771164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DISTRIBUTION AND UTILISATION OF IVERMECTIN (MECTIZAN): A CHEMOTHERAPEUTIC APPROACH TO THE CONTROL OF ONCHOCERCIASIS IN OLD OHAOZARA LGA, EBONYI STATE, EASTERN NIGERIA.
    Okpara EM; Mnaemeka AM; Iyioku UU; Udoh UV
    J Egypt Soc Parasitol; 2015 Dec; 45(3):663-70. PubMed ID: 26939245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The efficacy and tolerance of ivermectin (Mectizan) prescribed for the patient with multiple filarial infections (Loa loa/Onchocerca and/or M. perstans)].
    Richard-Lenoble D; Kombila M; Chandenier J; Gaxotte P
    Bull Soc Pathol Exot Filiales; 1989 Jan; 82(1):65-71. PubMed ID: 2743519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.